Pharmacologic inhibition of the nuclear factor erythroid 2-related factor 2/glutathione pathway via brusatol administration exhibited a potent tumor suppressive effect on IDH1-mutated glioma in vitro and in vivo [18]. The gene discussed is NFE2L2; the disease is glioma.